The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•17 April 2026•

1 min read

Vivos Therapeutics Closes Private Placement with New Seneca Partners

Key Facts

1Vivos Therapeutics closed a private placement with V-Co Investors 3 LLC, an affiliate of New Seneca Partners Inc.

2Vivos Therapeutics is a medical device company listed on NASDAQ under the ticker VVOS.

Vivos Therapeutics, Inc. (NASDAQ: VVOS), a medical device company, has successfully closed a private placement with V-Co Investors 3 LLC, an affiliate of New Seneca Partners Inc. This strategic funding round is designed to secure the necessary capital to support the company’s ongoing operations within the medical device and healthcare services sectors. Vivos specializes in innovative treatments for sleep apnea, and this private equity injection aims to bolster its financial position. While the placement provides essential liquidity, it may lead to potential share dilution for existing shareholders, a common factor in private equity financing. The company continues to leverage its relationship with existing investors to navigate its growth trajectory. Market participants are closely watching the impact of this capital raise on the company's long-term valuation and operational scale.